These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22922157)

  • 1. [Biological therapies in systemic lupus erythematosus].
    Suszek D; Jeleniewicz R; Majdan M
    Postepy Hig Med Dosw (Online); 2012 Aug; 66():568-73. PubMed ID: 22922157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
    Harvey PR; Gordon C
    BioDrugs; 2013 Apr; 27(2):85-95. PubMed ID: 23456653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recombinant proteins or monoclonal antibodies: comparative properties and interest in systemic lupus erythematosus].
    Terrier B; Mouthon L
    Med Sci (Paris); 2013 Jan; 29(1):65-73. PubMed ID: 23351696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging biological therapies for systemic lupus erythematosus.
    Mok CC
    Expert Opin Emerg Drugs; 2014 Jun; 19(2):303-22. PubMed ID: 24588398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Belimumab for the treatment of systemic lupus erythematosus.
    Jordan N; D'Cruz DP
    Expert Rev Clin Immunol; 2015 Feb; 11(2):195-204. PubMed ID: 25543845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.
    Fattah Z; Isenberg DA
    Expert Opin Biol Ther; 2014 Mar; 14(3):311-26. PubMed ID: 24387632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell-targeted therapy for systemic lupus erythematosus: an update.
    Ding C; Foote S; Jones G
    BioDrugs; 2008; 22(4):239-49. PubMed ID: 18611066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Belimumab, a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus.
    Espinosa G; Cervera R
    Drugs Today (Barc); 2010 Dec; 46(12):891-9. PubMed ID: 21589946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell-depleting therapy in systemic lupus erythematosus.
    Ramos-Casals M; Sanz I; Bosch X; Stone JH; Khamashta MA
    Am J Med; 2012 Apr; 125(4):327-36. PubMed ID: 22444096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of biologic therapies for systemic lupus erythematosus treatment: systematic review and meta-analysis.
    Borba HH; Wiens A; de Souza TT; Correr CJ; Pontarolo R
    BioDrugs; 2014 Apr; 28(2):211-28. PubMed ID: 24190520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics in SLE: towards new approaches.
    van Vollenhoven RF; Parodis I; Levitsky A
    Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):341-9. PubMed ID: 24238691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Belimumab: a BLyS-specific inhibitor for systemic lupus erythematosus.
    Wiglesworth AK; Ennis KM; Kockler DR
    Ann Pharmacother; 2010 Dec; 44(12):1955-61. PubMed ID: 21081710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell-targeted therapies for systemic lupus erythematosus: an update on clinical trial data.
    Looney RJ
    Drugs; 2010 Mar; 70(5):529-40. PubMed ID: 20297867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breaking the ice in systemic lupus erythematosus: belimumab, a promising new therapy.
    Mosak J; Furie R
    Lupus; 2013 Apr; 22(4):361-71. PubMed ID: 23553779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.
    Jordan NP; D'Cruz DP
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1635-45. PubMed ID: 26327145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell targeted treatments for lupus: the journey counts as much as the destination.
    Falgarone G; Dhote R; Boissier MC
    Joint Bone Spine; 2012 Oct; 79(5):437-40. PubMed ID: 22480746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Belimumab: anti-BLyS human monoclonal antibody, anti-BLyS monoclonal antibody, BmAb, human monoclonal antibody to B-lymphocyte stimulator.
    Drugs R D; 2008; 9(3):197-202. PubMed ID: 18457473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biological treatments for systemic lupus erythematosus: current and future modalities.
    Bezalel S; Asher I; Elbirt D; Sthoeger ZM
    Isr Med Assoc J; 2012 Aug; 14(8):508-14. PubMed ID: 22977972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration.
    Poh YJ; Baptista B; D'Cruz DP
    Expert Rev Clin Immunol; 2017 Oct; 13(10):925-938. PubMed ID: 28847197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.